Autotelicbio
Clinical trials sponsored by Autotelicbio, explained in plain language.
-
New drug ATB-320 enters first human tests for advanced cancers
Disease control Not yet recruitingThis early-stage study tests a new drug, ATB-320, in 24 adults with solid tumors that have spread or are getting worse despite standard treatments. The main goal is to find a safe dose and check for side effects. Participants must provide tumor samples and have tumors that can be…
Phase: PHASE1 • Sponsor: Autotelicbio • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New combo pill for diabetes and hypertension enters early human testing
Knowledge-focused Not yet recruitingThis early-stage trial will test a new tablet that combines two common drugs—one for type 2 diabetes and one for high blood pressure—in healthy volunteers. The goal is to see if the single pill works the same in the body as taking the two drugs separately. Thirty-six healthy adul…
Phase: PHASE1 • Sponsor: Autotelicbio • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC